Dr Rasika Samarasinghe



Teaching Scholar - Medical Biotechnology and Infection and Immunity


Faculty of Health


School of Medicine


Geelong Waurn Ponds Campus


Graduate Certificate of Higher Education Learning and Teaching, Deakin University, 2019

Research interests

Epigenetic therapies in pediatric diseases

Epigenetic factors in bone disorders

Inflammatory and degenerative diseases



Inflammation Research Association (from 2010)

American Association for the Advancement of Science (from 2010)

Golden Key International Honour Society (from 2008)

Teaching interests

Medical Biotechnology




Knowledge areas

Epigenetics, Cancer, Inflammatory diseases, Nanomedicine, Drug and Cell therapy


  • 14th Asian Society for Neuro-Oncology (ASNO) Meeting, Osaka, Japan, 2017.
  • 10th COGNO Annual Scientific Meeting: Tailoring Therapies for Brain Tumours: Challenges and Opportunities, Melbourne, Australia, 2017.
  • 13th Asian Society for Neuro-Oncology Meeting/ 9th COGNO Annual Scientific Meeting, Sydney, Australia, 2016.
  • Barwon Health Research Week, Geelong, Australia, 2015.
  • Weizmann symposium – Future directions in cancer biology & targeted therapeutics, Melbourne, Australia, 2015.
  • 17th International Inflammation Research Association Conference, New York, USA, 2012.
  • 3rd Sydney International Nanomedicine Conference, Sydney, Australia, 2012.
  • 2nd Sydney International Nanomedicince conference, Sydney, Australia, 2011.


  • Scientist Prize – Most Outstanding Research Presentation - Barwon Health Research Week, Geelong (2015)
  • Early Career Researcher - Best Top 5 presentations - Weizmann symposium – Future directions in cancer biology & targeted therapeutics, Melbourne (2015)
  • Publication Scholarship - Deakin University (2013)
  • Best PhD poster presentation - 17th International Inflammation Research Association Conference, New York, USA (2012)
  • Best 3rd/4th year PhD oral presenter - Institute for Frontier Materials (IFM), Annual Research Conference (2012)
  • Best 1st year PhD oral presenter, Institute for Frontier Materials (IFM), Annual Research Conference (2009)


Filter by


Antibodies, nanobodies, or aptamers-which is best for deciphering the proteomes of non-model species?

P Dhar, R Samarasinghe, S Shigdar

(2020), Vol. 21, pp. 1-14, International journal of molecular sciences, Basel, Switzerland, C1

journal article

Phenotyping neurons activated in the mouse brain during restoration of salt debt

Craig Smith, Joshua Cross, Izel Eraslan, Aparna Attawar, Sarah Ch?ng, Poshmaal Dhar, Rasika Samarasinghe, Laura Gray, Andrew Lawrence

(2019), Vol. 101, pp. 1-9, Journal of chemical neuroanatomy, Amsterdam, The Netherlands, C1

journal article

Multimodal nanomedicine strategies for targeting cancer cells as well as cancer stem cell signalling mechanisms

J Kanwar, R Samarasinghe, S Kamalapuram, R Kanwar

(2017), Vol. 17, pp. 1-8, Mini reviews in medicinal chemistry, Beijing, China, C1

journal article

Role of nanomedicine in arthritic disorders

R Samarasinghe, R Kanwar, J Kanwar

(2015), Vol. 1, pp. 281-311, NanoBioMedicine Vol. 1: Nanomedicine, Houston, Tex., B1-1

book chapter

Cissus quadrangularis inhibits IL-1? induced inflammatory responses on chondrocytes and alleviates bone deterioration in osteotomized rats via p38 MAPK signaling

J Kanwar, R Samarasinghe, K Kumar, R Arya, S Sharma, S Zhou, S Sasidharan, R Kanwar

(2015), Vol. 9, pp. 2927-2940, Drug Design, Development and Therapy, [Auckland, N.Z.], C1

journal article

Antiarthritic and chondroprotective activity of Lakshadi Guggul in novel alginate-enclosed chitosan calcium phosphate nanocarriers

R Samarasinghe, R Kanwar, K Kumar, J Kanwar

(2014), Vol. 9, pp. 819-837, Nanomedicine, London, England, C1

journal article

The effect of oral administration of iron saturated-bovine lactoferrin encapsulated chitosan-nanocarriers on osteoarthritis

R Samarasinghe, R Kanwar, J Kanwar

(2014), Vol. 35, pp. 7522-7534, Biomaterials, C1

journal article

Nanotechnology based platforms for survivin targeted drug discovery

R Samarasinghe, J Gibbons, R Kanwar, J Kanwar

(2012), Vol. 7, pp. 1083-1092, Expert Opinion on Drug Discovery, C1

journal article

The role of nanomedicine in cell based therapeutics in cancer and inflammation.

R Samarasinghe, R Kanwar, J Kanwar

(2012), Vol. 1, pp. 133-144, International journal of molecular and cellular medicine, Babol, Iran, C1-1

journal article

Nano-lactoferrin in diagnostic, imaging and targeted delivery for cancer and infectious diseases

J Kanwar, R Samarasinghe, R Sehgal, R Kanwar

(2012), Vol. 4, pp. 31-42, Journal of Cancer Science and Therapy, C1-1

journal article

Funded Projects at Deakin

No Funded Projects at Deakin found


No completed student supervisions to report